Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin K Thomsen

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Oncotarget|November 27, 2023
The double-edge sword of CRISPR application for <i>in vivo</i> studiesMartin K Thomsen
Cancers|October 27, 2022
Application of CRISPR for In Vivo Mouse Cancer StudiesMartin K Thomsen
Cancers|September 9, 2023
Pre-Clinical Models to Study Human Prostate CancerMartin K Thomsen, Morten Busk
Differentiation; Research in Biological Diversity|June 19, 2008
The role of Sox9 in prostate developmentMartin K Thomsen, Jeffrey C Francis, Amanda Swain
Plos Genetics|January 10, 2013
β-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinomaJeffrey C Francis, Martin K Thomsen, Makoto M Taketo, et al.
Developmental Biology|March 8, 2008
Sox9 is required for prostate developmentMartin K Thomsen, Christopher M Butler, Michael M Shen, et al.
Plos Genetics|June 30, 2010
Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesisJeffrey C Francis, Afshan McCarthy, Martin K Thomsen, et al.
Journal of Visualized Experiments : Jove|May 15, 2018
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene AlterationMaria Riedel, Martin F Berthelsen, Latifa Bakiri, et al.
Hepatology (Baltimore, Md.)|May 25, 2013
Activator Protein 1 transcription factor Fos-related antigen 1 (Fra-1) is dispensable for murine liver fibrosis, but modulates xenobiotic metabolismSebastian C Hasenfuss, Latifa Bakiri, Martin K Thomsen, et al.
Current Opinion in Pharmacology|October 17, 2021
Three-dimensional culture models to study glioblastoma - current trends and future perspectivesJustin V Joseph, Mathilde S Blaavand, Thomas Daubon, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Oncotarget|November 27, 2023
The double-edge sword of CRISPR application for <i>in vivo</i> studiesMartin K Thomsen
Cancers|October 27, 2022
Application of CRISPR for In Vivo Mouse Cancer StudiesMartin K Thomsen
Cancers|September 9, 2023
Pre-Clinical Models to Study Human Prostate CancerMartin K Thomsen, Morten Busk
Differentiation; Research in Biological Diversity|June 19, 2008
The role of Sox9 in prostate developmentMartin K Thomsen, Jeffrey C Francis, Amanda Swain
Plos Genetics|January 10, 2013
β-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinomaJeffrey C Francis, Martin K Thomsen, Makoto M Taketo, et al.
Developmental Biology|March 8, 2008
Sox9 is required for prostate developmentMartin K Thomsen, Christopher M Butler, Michael M Shen, et al.
Plos Genetics|June 30, 2010
Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesisJeffrey C Francis, Afshan McCarthy, Martin K Thomsen, et al.
Journal of Visualized Experiments : Jove|May 15, 2018
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene AlterationMaria Riedel, Martin F Berthelsen, Latifa Bakiri, et al.
Hepatology (Baltimore, Md.)|May 25, 2013
Activator Protein 1 transcription factor Fos-related antigen 1 (Fra-1) is dispensable for murine liver fibrosis, but modulates xenobiotic metabolismSebastian C Hasenfuss, Latifa Bakiri, Martin K Thomsen, et al.
Current Opinion in Pharmacology|October 17, 2021
Three-dimensional culture models to study glioblastoma - current trends and future perspectivesJustin V Joseph, Mathilde S Blaavand, Thomas Daubon, et al.
Pageof 5